Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib

• Ruben Mesa,
• Srdan Verstovsek,
• Uwe Platzbecker,
• Vikas Gupta,
• David Lavie,
• Pilar Giraldo,
• Christian Recher,
• Jean-Jacques Kiladjian,
• Stephen T. Oh,
• Aaron T. Gerds,
• Timothy Devos,
• Francesco Passamonti,
• Alessandro M. Vannucchi,
• Miklos Egyed,
• Ewa Lech-Maranda,
• Andrzej Pluta,
• Lars Nilsson,
• Kazuya Shimoda,
• Donal McLornan,
• Jun Kawashima,
• Barbara Klencke,
• Mei Huang,
• Bryan Strouse,
• Claire Harrison

Affiliations

Ruben Mesa

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, NC

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center, Houston, TX

Uwe Platzbecker

Leipzig University Hospital, Leipzig

Vikas Gupta

Princess Margaret Cancer Centre, Toronto, Ontario

David Lavie

Hadassah-Hebrew University Medical Center, Jerusalem

Pilar Giraldo

Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza

Christian Recher

Institut Universitaire du Cancer de Toulouse, Université de Toulouse III, Toulouse

Jean-Jacques Kiladjian

Université Paris Cité, AP-HP, Ho_pital Saint-Louis, Centre d’Investigations Cliniques, INSERM, CIC1427, Paris

Stephen T. Oh

Washington University School of Medicine, St. Louis, MO

Aaron T. Gerds

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Timothy Devos

Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium

Francesco Passamonti

University of Insubria, Varese

Alessandro M. Vannucchi

University of Florence and AOU Careggi, Florence

Miklos Egyed

Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary

Ewa Lech-Maranda

Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Andrzej Pluta

Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow, Poland

Lars Nilsson

Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden

Kazuya Shimoda

University of Miyazaki, Miyazaki, Japan

Donal McLornan

Guy's and St Thomas' NHS Foundation Trust, London

Jun Kawashima

Sierra Oncology, Inc., San Mateo, CA

Barbara Klencke

Sierra Oncology, Inc., San Mateo, CA

Mei Huang

Sierra Oncology, Inc., San Mateo, CA

Bryan Strouse

Sierra Oncology, Inc., San Mateo, CA

Claire Harrison

Guy's and St Thomas' NHS Foundation Trust, London